DHR Danaher Corporation
Company Analysis
Latest News
🟢 Danaher is trading 4.07% up today after Q3 EPS beat and raised 2026 outlook
Danaher is trading up 4.07% at $233.37 on October 21 after Q3 adjusted EPS of $2.11 beat expectations of $1.92. - Revenue rose 8.5% to $6.6 billion. -...
🔴 Danaher is trading 5% down in pre-market; exact catalyst remains uncertain
Danaher is trading down 5.24% at $212.50 now; the precise catalyst for the decline remains uncertain. - Q3 adjusted EPS was $2.11, above the $1.92 estimate. -...
Danaher Beats on Earnings and Raises Guidance — So Why Are Investors Heading for the Exit?
Shares of Danaher slid 4.6% to $214.00 on October 21, moments after the life-sciences giant reported a third quarter that looked strong on paper: adjusted...
🔴 Danaher is trading 4.6% down in pre-market despite higher 2026 EPS guidance
Danaher is trading 4.6% down at $214.00 in pre-market; its release does not explain the decline. - It closed at $224.24 on October 20. - Third-quarter...
Danaher's third quarter 2026 earnings beat estimates as core revenue growth excluding respiratory reached 5.5%
Danaher reported third quarter 2026 results that exceeded analyst expectations on both the top and bottom lines, driven by an acceleration in bioprocessing...
Danaher Corporation Q3 2026 Earnings Preview: What Analysts Expect on October 21, 2026
Danaher is projected to report Q3 2026 revenue of $6.56 billion and adjusted EPS of $1.92, while shares trade at $229.04, slightly below the $235.41 average...
Danaher Names Julie Sawyer Montgomery President and CEO
Julie Sawyer Montgomery became President and Chief Executive Officer of Danaher Corporation on October 1, 2026. The board announced the appointment on August...
🔴 Danaher is trading 4.1% down today as rising Treasury yields pressure healthcare stocks
Danaher is trading at $212.50, down 4.09%, as healthcare-sector weakness and rising Treasury yields weigh on rate-sensitive stocks. - The 10-year Treasury...
🔴 Danaher is trading 24.96% down in after-hours trading — move remains unexplained
Danaher is trading at $165.99, down 24.96% after-hours; the sharp decline remains unexplained. - No credible company-specific announcement or earnings release...
🟢 Danaher is trading 7.16% up in after-hours trading with no clear catalyst identified
Danaher is trading 7.16% up at $217.79 after-hours, with no clear company-specific catalyst identified. - This compares with the September 14 regular-session...
OrbiMed Advisors exits entire $50.4M position in Danaher (DHR)
In a recent 13F filing, major healthcare investor OrbiMed Advisors revealed it had liquidated its entire stake in Danaher Corp. during the second quarter of...
Maverick Capital Exits $155 Million Stake in Danaher
Lee Ainslie's Maverick Capital fully divested its position in Danaher (DHR) during the second quarter of 2026, selling all 819.68K shares. The sale, valued at...
🟢 Danaher is trading 4.3% up today amid a healthcare-sector rally
Danaher is trading 4.3% up at $220.49, with the move appearing primarily sector-driven after Moderna’s late-stage cancer-therapy news. - Danaher extended its...
🟢 Danaher is trading 4.46% up today as healthcare rises on positive melanoma vaccine results
Danaher is trading 4.46% up at $208.49, recovering from the August 18 close of $199.58 as healthcare gains followed positive late-stage melanoma vaccine...
🔴 Danaher is trading 19.21% down in after-hours trading with no new clearly attributable company-specific announcement identified
Danaher is trading at $166.29, down -19.21%, after no new, clearly attributable company-specific announcement was identified for August 12, 2026. - Earlier...
Danaher Appoints Julie Sawyer Montgomery as New President and Chief Executive Officer
Danaher Corporation announced the appointment of Julie Sawyer Montgomery as its next President and Chief Executive Officer, effective October 1, 2026. She will...
🟢 Danaher is trading 5% up today on strong Q2 results and Masimo deal completion
Danaher is trading up 5% at $206.24, extending a multi-session rally following strong Q2 results and the earlier-than-expected completion of its Masimo...
🟢 Danaher is trading 5.1% up
Danaher is trading at $188.30, up 5.1% from a comparison close of $179.14 during regular trading. This is a price-action follow-up, so a separate catalyst may...
Danaher Beat on Every Number That Matters — So Why Did Investors Erase $28 Billion in a Single Morning?
Shares of Danaher cratered 14.2% to $172.57 on July 21 after the life-sciences conglomerate delivered a second quarter that topped Wall Street estimates on...
🔴 Danaher is trading 14.2% down today as weak biotech revenue offsets earnings beat
Danaher is trading 14.2% down today at $172.57 after releasing second-quarter 2026 results and updating its full-year outlook. • While the company beat...